According to George Perros, Greystone Research Managing Director, evolution in pain management guidelines and a better appreciation for pain-associated morbidity by clinicians are making pain management more essential for patients. Greystone’s study, “Transdermal Pain Management to 2015,” analyses commercial transdermal prescription drug products and development-stage candidates, as well as examining key factors influencing market demand and shaping growth prospects.
Read the Greystone Research Associates press release on transdermal pain products.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.